Health-related outcomes in patients with lumbar intervertebral disc disorders and comorbid arteriosclerosis or dyslipidaemia: a scoping review
With the increasing prevalence of lumbar intervertebral disc disorders (LIDDs) in the ageing population, arteriosclerosis and dyslipidaemia may contribute to their development or progression. However, the impact of comorbid arteriosclerosis or dyslipidaemia on changes in health-related outcomes remains unclear. This scoping review evaluated changes in health-related outcomes among patients with LIDDs and arteriosclerosis/dyslipidaemia, and identified variables adjusted for in the included studies. We searched Ovid MEDLINE, CENTRAL, and EMBASE from inception to December 18, 2025. Studies investigating health-related outcomes among patients with LIDDs and arteriosclerosis/dyslipidaemia were included without language or study design restrictions. Methodological quality of the included studies was assessed using the National Heart, Lung and Blood Institute study quality assessment tools. Data regarding health-related outcome types, outcome directions, and adjusted variables were extracted and summarised narratively. Of 794 records identified, seven studies involving 2,099 patients met the inclusion criteria. Two studies included patients with comorbid arteriosclerosis, and five with comorbid dyslipidaemia. Reported outcomes included all-cause mortality, bone fusion, surgical efficacy, surgical site infection, changes in visceral fat area, and recurrence rates. Both studies examining arteriosclerosis comorbidity reported associations in poorer outcome direction, although their outcomes and analytical approaches differed. The impact of comorbid dyslipidaemia remained inconsistent. Methodological quality was rated as “poor” in four studies, and “fair” in three. Age and sex were the most frequently adjusted variables. Given the limited number, heterogeneity, and methodological weaknesses of the included studies, the current evidence is insufficient to support or refute an association between comorbid arteriosclerosis or dyslipidaemia and health-related outcomes in patients with LIDDs. Evidence suggesting poorer health-related outcomes in patients with comorbid arteriosclerosis is limited. Findings regarding the association between comorbid dyslipidaemia and health-related outcomes remain inconsistent. Given these important evidence gaps, robust longitudinal studies with adequate adjustment for clinically relevant confounders are needed.
Authors
- Hyangsook Lee (ORCID: https://orcid.org/0000-0002-1107-9389)
- 배인후
- Ye-Seul Lee
- Song-Yi Kim
Institutions
- Gachon University (KR)
- Kyung Hee University (KR)
- Jaseng Medical Foundation (KR)
Publication Details
- Journal
- BMC Musculoskeletal Disorders
- Published
- 2026-11-20
- DOI
- https://doi.org/10.1186/s12891-026-10763-7
- Primary Topic
- Spine and Intervertebral Disc Pathology
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Korea Health Industry Development Institute
- National Research Foundation of Korea